Development of a novel therapy targeting tumor microenvironment of malignant pleural mesothelioma
Project/Area Number |
25861255
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Respiratory surgery
|
Research Institution | Kyushu University |
Principal Investigator |
Morodomi Yosuke 九州大学, 医学(系)研究科(研究院), 助教 (60645365)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 悪性胸膜中皮腫 / ウロキナーゼ / ウロキナーゼ受容体 |
Outline of Final Research Achievements |
We examined the relationship between the expression of urokinase-type plasminogen activator receptor (uPAR) and the clinicopathologic features of malignant pleural mesothelioma. As a result, the patients with high expression of uPAR had significantly shorter prognosis than the low expression patients. Additionally, we found hypoxic condition promote the expression of uPAR in mesothelioma cell lines, suggesting that the condition facilitate the invasiveness of mesothelioma. Therefore, suppressing uPAR may be a novel target of malignant pleural mesothelioma for treatment or diagnosis.
|
Report
(4 results)
Research Products
(4 results)
-
[Journal Article] Associations Between Driver Gene Mutations and Cytotoxic Chemosensitivity in Patients with Non-small Cell Lung Cancer.2015
Author(s)
Morodomi Y, Okamoto T, Kohno M, Katsura M, Takada K, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Yoshida T, Tagawa T, Okano S, Maehara Y
-
Journal Title
Anticancer Research
Volume: 35
Pages: 1791-1796
Related Report
Peer Reviewed
-
-
-